We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.82%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.87B
AUM Growth
-$13.1M
(-0.34%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
372
New
16
Increased
96
Reduced
171
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$7.62M |
| 2 |
Constellation Brands
STZ
|
+$4.4M |
| 3 |
CHX
ChampionX
CHX
|
+$3.45M |
| 4 |
Stanley Black & Decker
SWK
|
+$3.4M |
| 5 |
Valero Energy
VLO
|
+$2.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$41.6M |
| 2 |
Check Point Software Technologies
CHKP
|
+$11.3M |
| 3 |
Medtronic
MDT
|
+$9.78M |
| 4 |
Franklin Resources
BEN
|
+$8.22M |
| 5 |
CELG
Celgene Corp
CELG
|
+$7.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 17.92% |
| 3 | Financials | 11.59% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Suncor Energy
SU
$78.8B
| $14.8M | 0.38% |
364,120
+4,053
| +1% | +$158K |
|
77
Edwards Lifesciences
EW
$50B
| $14.4M | 0.37% |
296,466
-19,455
| -6% | -$908K |
|
|
MZTI
78
The Marzetti Company
MZTI
$2.95B
| $14.2M | 0.37% |
102,559
-1,656
| -2% | -$212K |
|
79
IBM
IBM
$209B
| $14M | 0.36% |
105,086
-4,092
| -4% | -$571K |
|
80
CVS Health
CVS
$134B
| $13.8M | 0.36% |
214,521
-71,352
| -25% | -$4.7M |
|
81
Dover
DOV
$27.5B
| $13.7M | 0.35% |
187,010
-70,696
| -27% | -$5.41M |
|
|
82
Valero Energy
VLO
$92.6B
| $13.6M | 0.35% |
122,743
+25,890
| +27% | +$2.9M |
|
83
GE Aerospace
GE
$368B
| $13.3M | 0.34% |
204,323
-33,264
| -14% | -$2.22M |
|
84
Boston Scientific
BSX
$68.4B
| $13M | 0.34% |
396,520
-1,069
| -0.3% | -$32.2K |
|
|
85
Constellation Brands
STZ
$22.3B
| $12.9M | 0.33% |
58,750
+19,483
| +50% | +$4.4M |
|
86
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $12.7M | 0.33% |
297,006
+1,911
| +0.6% | +$85.2K |
|
87
Sysco
SYY
$40.6B
| $12.7M | 0.33% |
186,437
-4,175
| -2% | -$267K |
|
88
Bristol-Myers Squibb
BMY
$132B
| $12.5M | 0.32% |
225,025
-4,753
| -2% | -$257K |
|
89
Eli Lilly
LLY
$1.03T
| $12.1M | 0.31% |
141,582
-2,705
| -2% | -$222K |
|
90
Emerson Electric
EMR
$83.3B
| $11.6M | 0.3% |
168,097
+919
| +0.5% | +$64.6K |
|
91
Cummins
CMI
$87.3B
| $11.4M | 0.3% |
86,070
-2,875
| -3% | -$430K |
|
92
Gilead Sciences
GILD
$163B
| $10.5M | 0.27% |
147,740
-7,927
| -5% | -$560K |
|
93
Walmart Inc
WMT
$884B
| $10.3M | 0.27% |
359,682
-2,430
| -0.7% | -$69.1K |
|
94
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $10.1M | 0.26% |
239,607
-4,250
| -2% | -$192K |
|
|
95
Thermo Fisher Scientific
TMO
$214B
| $9.93M | 0.26% |
47,955
+35,913
| +298% | +$7.62M |
|
96
Qualcomm
QCOM
$160B
| $9.65M | 0.25% |
172,009
-3,704
| -2% | -$207K |
|
|
CVGW
97
DELISTED
Calavo Growers
CVGW
| $9.63M | 0.25% |
100,120
+12,279
| +14% | +$1.14M |
|
98
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $9.5M | 0.25% |
35,033
+1,555
| +5% | +$420K |
|
99
Lincoln Electric
LECO
$13.7B
| $9.48M | 0.25% |
108,010
+4,845
| +5% | +$431K |
|
|
TIF
100
DELISTED
Tiffany & Co.
TIF
| $9.11M | 0.24% |
69,226
-445
| -0.6% | -$50.8K |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q2 2018 Portfolio in Review
As of Q2 2018, Welch & Forbes held 372 positions worth $3.87B, down 0.34% from $3.88B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Welch & Forbes withdrew a net $131M in Q2 2018, closing 13 positions and reducing 171 holdings. Its most notable exit was Chubb, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Welch & Forbes opened a new position in ChampionX worth $3.52M.
- Welch & Forbes's largest Q2 2018 buy was ChampionX: 84,371 shares worth $3.52M.
- Welch & Forbes added most to Thermo Fisher Scientific in Q2 2018, an estimated $7.62M increase.
- Welch & Forbes's biggest Q2 2018 reduction was Franklin Resources, cutting an estimated $8.22M.
- Welch & Forbes fully exited Chubb in Q2 2018, selling an estimated $41.6M.
- Welch & Forbes's ten largest holdings make up 24% of its $3.87B portfolio in Q2 2018.
- Welch & Forbes opened 16 new positions and closed 13 in Q2 2018.
- Welch & Forbes's portfolio value fell 0.34% quarter-over-quarter to $3.87B.
Based on Welch & Forbes's 13F filing for Q2 2018, filed 16 Jul 2018.